Access the full text.
Sign up today, get DeepDyve free for 14 days.
K Kozak, BL Smith, J Adams (2006)
Accelerated partial-breast irradiation using proton beams: initial clinical experienceInt J Radiat Oncol Biol Phys, 66
T Whelan, J-P Pignol, M Levine (2010)
Long-term results of hypofractionated radiation therapy for breast cancerN Engl J Med, 362
T Whelan, J-P Pignol, J Julian (2008)
Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancerInt J Radiat Oncol Biol Phys, 72
F Vicini, P Chen, M Wallace (2007)
Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapyInt J Radiat Oncol Biol Phys, 69
S Formenti, MT Truong, JD Goldberg (2004)
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose–volume histogram analysisInt J Radiat Oncol Biol Phys, 60
W Suh, LJ Pierce, FA Vicini, JA Hayman (2005)
A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancerInt J Radiat Oncol Biol Phys, 62
J-P Pignol, E Rakovitch, B Keller (2009)
Tolerance and acceptance results of a palladium-103 permanent breast seed implant phase I/II studyInt J Radiat Oncol Biol Phys, 73
DJ Hoopes, D Kaziska, P Chapin (2012)
Patient preferences and physician practice patterns regarding breast radiotherapyInt J Radiat Oncol Biol Phys, 82
F Vicini, K Winter, W Straube (2005)
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of radiation therapy oncology group (RTOG) study 0319Int J Radiat Oncol Biol Phys, 63
AT Schroen, GR Petroni, H Wang (2012)
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. coop oncol groupClin Cancer Res, 18
J Yarnold, A Ashton, J Bliss (2005)
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: longterm results of a randomised trialRadiother Oncol, 75
R Osteen, LH Karnell (1994)
The national cancer data base report on breast cancerCancer, 73
E Elkin, C Hudis, C Begg, D Schrag (2005)
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999Cancer, 104
B Smith, S Bentzen, CR Correa (2011)
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guidelineInt J Radiat Oncol Biol Phys, 81
T Whelan, M Levine, J Julian (2000)
The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario clinical oncology groupCancer, 88
B Smith, D Arthur, TA Buchholz (2009)
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)Int J Radiat Oncol Biol Phys, 74
J Vaidky, DJ Joseph, JS Tobias (2010)
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialLancet, 376
B Fisher, S Anderson, J Bryant (2002)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancerN Engl J Med, 347
T Hack, LF Gedner, P Watson, L Sinha (2005)
Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancerPsych Oncol, 15
M Clarke, R Collins, S Darby (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trialsLancet, 366
U Veronesi, N Cascinelli, L Mariani (2002)
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerN Engl J Med, 347
Yarnold, JB Magee, J Bliss (2008)
The UK standardization of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trialLancet, 371
W Anderson, I Jatoi, SS Devesa (2006)
Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943–2002)Breast Cancer Res Treat, 99
F Vicini, PD Beitsch, CA Quiet (2008)
Three-year analysis of treatment efficacy, cosmesis, and toxicity by the american society of breast surgeons MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI)Cancer, 112
This study was conducted to elucidate patients with early breast cancer preference for standard whole breast irradiation (WBI) or partial breast irradiation (PBI) following lumpectomy, as well as identify important factors for patients when making their treatment decisions. Based on relevant literature and ASTRO consensus statement guidelines, an educational tool and questionnaire were developed. Consenting, eligible women reviewed the educational tool and completed the trade-off questionnaire. Descriptive statistics were calculated, as well as chi-squares and a logistic regression model. Of the 90 patients who completed the study, 62 % preferred WBI, 30 % preferred PBI, 4 % required more information, and 3 % had no preferences. Of the patients who chose WBI, 58 % preferred hypofractionated RT, whereas 25 % preferred the conventional RT regimen. The majority of patients rated recurrence rate [WBI = 55/55 (100 %), PBI = 26/26 (100 %)] and survival [WBI = 54/55 (98 %), PBI = 26/26 (100 %)] as important factors contributing to their choice of treatment preference. Financial factors [WBI = 21/55 (38 %), PBI = 14/26 (53 %)] and convenience [WBI = 36/54 (67 %), PBI = 18/26 (69 %)] were rated as important less frequently. Significantly, more patients who preferred WBI also rated standard method of treatment as important when compared to patients who preferred PBI [WBI = 52/54 (96 %), PBI = 16/26 (61 %), χ 2 = 16.63, p = 0.001]. The majority of patients with early breast cancer who were surveyed for this study preferred WBI as an adjuvant treatment post lumpectomy, yet there was a sizeable minority who preferred PBI. This was associated with the importance patients place on standard treatment. These results will help medical professionals treat patients according to patient values.
Journal of Cancer Education – Springer Journals
Published: Mar 15, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.